In this study, we show that E2 and the selective GPER ligand G-1 up-regulate miR144 expression through the GPER and the involvement of the PI3K/ERK1/2/Elk1 transduction pathway in both breast cancer and hepatocarcinoma cells. This evidence concerns the gene MAPK3 and breast carcinoma.